In the BioHarmony Drug Report Database
Clazakizumab
Clazakizumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against interleukin-6.
Trade Name
|
|
|---|---|
Common Name
|
clazakizumab |
ChEMBL ID
|
CHEMBL2108589 |
Indication
|
|
Drug Class
|
Monoclonal antibodies: humanized, interleukins as target |
Image (chem structure or protein)
